Breakthrough peptide inhibitor effective against multiple SARS-CoV-2 variants

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors.

How can microdialysis benefit drug development

In this interview, discover how Charles River uses the power of microdialysis for drug development as well as CNS therapeutics.

September 3, 2024

American Heart Association recognizes 3147 organizations for commitment to improving cardiovascular care

Someone in the United States dies of cardiovascular disease (CVD) every 34 seconds, on average. Reducing deaths from CVD requires a coordinated approach to care

July 17, 2024

Lithium for Bipolar Disorder Linked to Higher Risk of Thyroid, Kidney Dysfunction

Lithium was associated with a higher risk of thyroid and kidney dysfunction versus non-lithium treatments in bipolar disorder patients. Associations were dose-dependent and serum level

February 12, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.